V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20221994 | 20084366 | 1.53 | 88.6 | null | 2016-11-25 | 2016-11-26 | Enzalutamide | null | null | CETUXIMAB + OXALIPLATIN + MDG | 100797936 |
| 20222001 | 20084367 | 1.8 | 99 | Palliative (P) | 2018-05-17 | 2018-06-04 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101191377 |
| 20222003 | 20084368 | 1.77 | 74.2 | Palliative (P) | 2017-01-04 | 2017-01-31 | Enzalutamide | 02 | N | CETUXIMAB | 101097836 |
| 20222014 | 20084369 | 1.75 | 78 | Neo-adjuvant (N) | 2019-04-09 | 2019-04-09 | Enzalutamide | 2 | Y | CARBOPLATIN | 100735318 |
| 20222016 | 20084370 | 1.85 | 59 | Curative (C) | 2018-08-17 | 2018-09-29 | Enzalutamide | N | Y | SCALOP-2 TRIAL | 100281041 |
| 20222019 | 20084371 | 1.77 | 77.4 | null | 2019-09-18 | 2019-09-18 | LUTETIUM-177 | 02 | null | LUTETIUM-177 | 101290252 |
| 20222020 | 20084372 | 1.72 | 108 | Palliative (P) | 2015-10-16 | 2015-10-25 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + RT | 101124081 |
| 20222023 | 20084373 | 1.52 | 55 | Palliative (P) | 2017-07-01 | 2017-07-01 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100787792 |
| 20222025 | 20084374 | 1.7 | 82.2 | Palliative (P) | 2019-04-25 | 2019-04-26 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100851418 |
| 20222028 | 20084375 | 1.77 | 81.5 | null | 2017-01-12 | 2017-01-27 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101649831 |
| 20222030 | 20084376 | 1.7 | 95.5 | Palliative (P) | 2017-08-28 | 2017-09-11 | OCTREOTIDE | 2 | Y | TRASTUZUMAB | 100212942 |
| 20222039 | 20084377 | 1.6 | 61.4 | Palliative (P) | 2018-12-17 | 2018-12-24 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101227063 |
| 20222040 | 20084378 | 1.64 | 63.1 | null | 2016-03-31 | 2016-05-05 | Enzalutamide | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100813336 |
| 20222043 | 20084379 | 1.7 | null | Adjuvant (A) | 2018-11-20 | 2018-11-25 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN + RT | 100625182 |
| 20222045 | 20084380 | 1.78 | 0 | null | 2018-10-17 | 2018-10-17 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100210856 |
| 20222048 | 20084381 | 1.55 | 67.2 | Curative (C) | 2019-01-13 | 2019-01-27 | CARBOPLATIN + PACLITAXEL + RT | N | N | CARBOPLATIN + PACLITAXEL + RT | 101251843 |
| 20222059 | 20084382 | 1.73 | 113 | Disease modification (D) | 2018-08-25 | 2018-08-25 | Enzalutamide | 99 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101167547 |
| 20222060 | 20084383 | 1.61 | 78.8 | Palliative (P) | 2019-11-27 | 2019-12-21 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101859017 |
| 20222061 | 20084384 | 1.58 | 62.4 | null | null | 2019-07-23 | Mitomycin Intravesical | N | null | MITOMYCIN INTRAVESICULAR | 101543038 |
| 20222062 | 20084385 | 1.66 | 48 | Palliative (P) | 2017-07-24 | 2017-07-25 | Enzalutamide | 02 | N | CARBOPLATIN | 100194213 |
| 20222067 | 20084386 | 1.54 | 83.5 | Palliative (P) | 2017-02-17 | 2017-02-17 | Enzalutamide | N | N | CISPLATIN | 101735923 |
| 20222069 | 20084387 | 0 | 0 | Curative (C) | null | 2019-07-12 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101007164 |
| 20222070 | 20084388 | 1.59 | 56.3 | Palliative (P) | 2017-09-09 | 2017-09-09 | Enzalutamide | N | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101135898 |
| 20222076 | 20084389 | 1.62 | 68.3 | Palliative (P) | 2021-01-17 | 2021-01-17 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100245512 |
| 20222084 | 20084390 | 1.79 | 135.5 | Palliative (P) | 2017-08-18 | 2017-09-11 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 100449058 |
| 20222102 | 20084391 | 1.88 | null | Palliative (P) | 2017-10-13 | 2017-10-25 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100246224 |
| 20222104 | 20084392 | 1.72 | 79.9 | Curative (C) | 2017-08-17 | 2017-08-26 | Enzalutamide | null | N | OXALIPLATIN + RALTITREXED | 100259480 |
| 20222108 | 20084393 | 1.82 | null | null | 2016-03-23 | 2016-03-23 | Enzalutamide | 02 | null | CISPLATIN | 100415106 |
| 20222109 | 20084394 | 1.77 | 92.2 | Palliative (P) | 2016-07-06 | 2016-07-13 | Enzalutamide | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101776517 |
| 20222117 | 20084395 | 1.62 | 80.55 | Curative (C) | 2016-07-16 | 2016-07-16 | Enzalutamide | null | N | CARBOPLATIN | 100194140 |
| 20222119 | 20084396 | 0 | 0 | null | 2018-03-07 | 2018-03-16 | Enzalutamide | N | N | CARBOPLATIN + GEMCITABINE | 101295288 |
| 20222130 | 20084397 | 1.68 | 74.7 | null | 2017-06-30 | 2017-07-03 | Enzalutamide | 2 | null | CISPLATIN | 101386499 |
| 20222134 | 20084398 | 1.73 | 59 | null | 2018-04-28 | 2018-04-30 | Enzalutamide | 2 | N | TRASTUZUMAB | 101074999 |
| 20222144 | 20084399 | 1.79 | 57.4 | Disease modification (D) | null | 2017-06-11 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100049395 |
| 20222145 | 20084400 | 1.91 | 101.1 | Curative (C) | 2016-07-16 | 2016-07-17 | OCTREOTIDE | N | N | CARBOPLATIN + GEMCITABINE | 101584749 |
| 20222151 | 20084401 | 1.8 | 101.1 | null | 2016-03-19 | 2016-05-08 | Enzalutamide | 02 | null | ECF | 100641198 |
| 20222158 | 20084402 | 1.63 | 65.2 | Curative (C) | 2019-02-13 | 2019-02-24 | Enzalutamide | 02 | null | OCTREOTIDE | 101567823 |
| 20222159 | 20084403 | 1.55 | 73.4 | Palliative (P) | 2016-01-24 | 2016-02-23 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101429583 |
| 20222165 | 20084404 | 1.76 | 67.3 | Palliative (P) | 2016-07-01 | 2016-07-02 | Enzalutamide | N | N | ENZALUTAMIDE | 101702190 |
| 20222169 | 20084405 | 1.65 | 76 | Palliative (P) | 2018-04-18 | 2018-04-24 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100008312 |
| 20222170 | 20084406 | null | null | null | 2018-09-09 | 2018-09-16 | SCALOP-2 Trial | 01 | null | SCALOP-2 TRIAL | 100506763 |
| 20222171 | 20084407 | 1.68 | 54.61 | Neo-adjuvant (N) | 2019-12-08 | 2019-12-08 | Enzalutamide | 02 | Y | CAPECITABINE + TEMOZOLOMIDE | 101213029 |
| 20222179 | 20084408 | 1.59 | 63.1 | Palliative (P) | 2016-06-15 | 2016-06-15 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101281353 |
| 20222188 | 20084409 | 1.56 | 56 | Palliative (P) | 2017-04-11 | 2017-04-19 | Enzalutamide | 02 | N | CARBOPLATIN | 100301951 |
| 20222190 | 20084410 | 1.76 | 50.2 | Curative (C) | 2018-04-20 | 2018-04-20 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100482105 |
| 20222199 | 20084411 | null | 57.1 | null | 2016-04-30 | 2016-05-17 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101379696 |
| 20222201 | 20084412 | 1.62 | 62.3 | Palliative (P) | 2020-12-10 | 2020-12-23 | Enzalutamide | N | N | ECF | 100589457 |
| 20222205 | 20084413 | 1.58 | 80.9 | null | 2016-11-05 | 2016-11-10 | Enzalutamide | 02 | null | CARBOPLATIN + GEMCITABINE | 101159359 |
| 20222215 | 20084414 | 1.51 | 98.9 | Neo-adjuvant (N) | 2017-05-26 | 2017-06-14 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN + RT | 101182657 |
| 20222222 | 20084415 | 1.65 | 82 | Neo-adjuvant (N) | 2018-11-04 | 2018-11-04 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 100945056 |